ThermiGyn to Announce Vulvovaginal Breakthroughs in Non-Surgical Vaginal Rejuvenation at IMCAS World Conference
Paris, France (PRWEB) January 28, 2015
ThermiGyn, a wholly owned subsidiary of ThermiHealth, a world leader in thermistor-regulated energy solutions for medical and aesthetic applications, will announce breakthroughs in non-surgical vaginal rejuvenation at the 17th Annual IMCAS World Conference in Paris on January 30th.
Aging, loss of collagen, and vaginal births can result in vulvolaxity and dryness both internally and externally. Pelvic organ prolapse, tissue stretching, and nerve impairment are known impediments of sexual satisfaction and well-being. Red Alinsod, MD, FACOG, FACS, ACGE will present the findings of a pilot study using the ThermiVa procedure to treat vulvovaginal tissue using temperature controlled radio frequency. Dr. Alinsod is a global leader in the area of temperature controlled RF for the treatment of vulvovaginal laxity, and he is the Chairman of the ThermiGyn Women’s Health Advisory Clinical Board.
In this pilot study, both vulvar laxity and vaginal laxity improved significantly for all patients after the first treatment and continued to improve after the third and final treatment. All participants reported improvement of sexual satisfaction as a result of the treatment. The primary endpoint of vulvovaginal tightening was achieved in all patients, and secondary endpoints of improved vaginal moisture and improved continence was achieved in selected patients with prior conditions. A larger multi-site IRB study has been approved, and participants are currently being selected.
Dr. Alinsod noted, “The potential for a simple and safe temperature controlled RF device to treat vulvovaginal laxity, atrophic vaginitis, mild to moderate stress incontinence, overactive bladder, and orgasmic dysfunctions holds great promise and could be transformational.”
ThermiHealth Technology
ThermiHealth Systems integrate precise thermistor controlled micro-invasive and non-invasive applicators into unique multiuse platforms. The micro-invasive applicators are true surgeons’ tools that provide surgeons a safe and effective instrument. Both the micro-invasive and the non-invasive applicators help the operator insure that specific tissue temperatures are achieved, maintained and monitored during procedures to help ensure safety and maximize results.
The ThermiAesthetics flagship product is the ThermiRF Temperature Controlled Radio Frequency Generator System and is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis, and to create lesions in nervous tissue.
About ThermiHealth
ThermiHealth is a privately held company developing a broad range of uses for thermistor controlled radio frequency technologies and for applications in the medical and aesthetic marketplaces.
ThermiAesthetics, a Division of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for Plastic Surgeons, Facial Plastic Surgeons, Dermatologist, Cosmetic Surgeons and other physicians serving the aesthetic market.
ThermiGyn, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for OB GYNs serving the women’s health marketplace.
ThermiEye, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for Ophthalmologists, Ocular Plastic Surgeons and other physicians serving the aesthetic market
For more information about ThermiHealth Companies, please visit http://www.thermi.com.
###
Tags: Announce, Breakthroughs, Conference, IMCAS, NonSurgical, Rejuvenation, ThermiGyn, Vaginal, Vulvovaginal, World